Clinical Trial Update: Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating 72-hour infusion of iloprost versus placebo in septic shock with organ failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Iloprost (Ventavis) (Iloprost)

Snippet

Sponsor: Jakob Stensballe, MD, PhD | Conditions: Septic Shock | Phase 2, Phase 3 | Status: COMPLETED